Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats

American Journal of Pathology

Volumn 174, Issue 3, 2009, Pages 881-890

  Nishikawa, Yuji ^a   Ohi, Naoto ^a   Yagisawa, Akiko ^a   Doi, Yuko ^a   Yamamoto, Yohei ^a   Yoshida, Masayuki ^a   Tokairin, Takuo ^a   Yoshioka, Toshiaki ^a   Omori, Yasufumi ^a   Enomoto, Katsuhiko ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; MESSENGER RNA; ORTHOVANADIC ACID; STEROID RECEPTOR COACTIVATOR 1; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STELLATE CELL;

EID: 62549106997     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080261     Document Type: Article

References (48)

1. Verma S, Cam MC, McNeill JH: Nutritional factors that can favorably influence the glucose/insulin system: vanadium. J Am Coll Nutr 1998, 17:11-18
2. Li J, Elberg G, Crans DC, Shechter Y: Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects. Biochemistry 1996, 35:8314-8318
3. Thompson KH, Orvig C: Vanadium in diabetes: 100 years from phase 0 to phase I. J Inorg Biochem 2006, 100:1925-1935
4. Denu JM, Lohse DL, Vijayalakshmi J, Saper MA, Dixon JE: Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci USA 1996, 93:2493-2498
5. Swarup G, Cohen S, Garbers DL: Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun 1982, 107:1104-1109
6. Klarlund JK: Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 1985, 41:707-717
7. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C: Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 1997, 272:843-851
8. Nishikawa Y, Doi Y, Watanabe H, Tokairin T, Omori Y, Su M, Yoshioka T, Enomoto K: Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. Am J Pathol 2005, 166:1077-1088
9. Ohi N, Nishikawa Y, Tokairin T, Yamamoto Y, Doi Y, Omori Y, Enomoto K: Maintenance of Bad phosphorylation prevents apoptosis of rat hepatic sinusoidal endothelial cells in vitro and in vivo. Am J Pathol 2006, 168:1097-1106
10. Schäfer S, Zerbe O, Gressner AM: The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 1987, 7:680-687
11. Jarvis TC, Alby LJ, Beaudry AA, Wincott FE, Beigelman L, McSwiggen JA, Usman N, Stinchcomb DT: Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA. RNA 1996, 2:419-428
12. Ohnishi H, Yamamori S, Ono K, Aoyagi K, Kondo S, Takahashi M: A src family tyrosine kinase inhibits neurotransmitter release from neuronal cells. Proc Natl Acad Sci USA 2001, 98:10930-10935
13. Edwards CA, O'Brien WD, Jr.: Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 1980, 104:161-167
14. Yokoi Y, Namihisa T, Matsuzaki K, Miyazaki A, Yamaguchi Y: Distribution of Ito cells in experimental hepatic fibrosis. Liver 1988, 8:48-52
15. Buck M, Kim DJ, Houglum K, Hassanein T, Chojkier M: c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells. Am J Physiol 2000, 278:G321-G328
16. Roskoski R, Jr.: Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005, 331:1-14
17. al-Bayati MA, Giri SN, Raabe OG, Rosenblatt LS, Shifrine M: Time and dose-response study of the effects of vanadate on rats: morphological and biochemical changes in organs. J Environ Pathol Toxicol Oncol 1989, 9:435-455
18. Nishikawa Y, Wang Z, Kerns J, Wilcox CS, Carr BI: Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs. Significance of protein tyrosine phosphatase inhibition. J Biol Chem 1999, 274:34803-34810
19. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF, Jr., Motomura K, Anania FA, Willson TM, Tsukamoto H: Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 2000, 275:35715-35722
20. Leyland H, Gentry J, Arthur MJ, Benyon RC: The plasminogen-activating system in hepatic stellate cells. Hepatology 1996, 24:1172-1178
21. Marra F, Gentilini A, Pinzani M, Choudhury GG, Parola M, Herbst H, Dianzani MU, Laffi G, Abboud HE, Gentilini P: Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology 1997, 112:1297-1306
22. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, Efsen E, Laffi G, Gentilini P: Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 1999, 30:951-958
23. Cao Q, Mak KM, Ren C, Lieber CS: Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways. J Biol Chem 2004, 279:4292-4304
24. Janiak A, Zemskov EA, Belkin AM: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 2006, 17:1606-1619
25. Breitkopf K, Sawitza I, Gressner AM: Characterization of intracellular pathways leading to coinduction of thrombospondin-1 and TGF-beta1 expression in rat hepatic stellate cells. Growth Factors 2005, 23:77-85
26. Carloni V, Defranco RM, Caligiuri A, Gentilini A, Sciammetta SC, Baldi E, Lottini B, Gentilini P, Pinzani M: Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells. Hepatology 2002, 36:582-591
27. Barker TH, Grenett HE, MacEwen MW, Tilden SG, Fuller GM, Settleman J, Woods A, Murphy-Ullrich J, Hagood JS: Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity. Exp Cell Res 2004, 295:488-496
28. Dudas J, Mansuroglu T, Batusic D, Saile B, Ramadori G: Thy-1 is an in vivo and in vitro marker of liver myofibroblasts. Cell Tissue Res 2007, 329:503-514
29. Ryder JW, Gordon JA: In vivo effect of sodium orthovanadate on pp60c-src kinase. Mol Cell Biol 1987, 7:1139-1147
30. Ishikawa Y, Kitamura M: Unexpected suppression of alpha-smooth muscle actin, the activation marker of mesangial cells, by pp60v-src tyrosine kinase. Biochem Biophys Res Commun 1998, 244:806-811
31. Hirshman CA, Zhu D, Pertel T, Panettieri RA, Emala CW: Isoproterenol induces actin depolymerization in human airway smooth muscle cells via activation of an Src kinase and GS. Am J Physiol 2005, 288:L924-L931
32. Yee HF, Jr.: Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton. Hepatology 1998, 28:843-850
33. Kato M, Iwamoto H, Higashi N, Sugimoto R, Uchimura K, Tada S, Sakai H, Nakamuta M, Nawata H: Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells. J Hepatol 1999, 31:91-99
34. Chang JH, Gill S, Settleman J, Parsons SJ: c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol 1995, 130:355-368
35. Arthur WT, Petch LA, Burridge K: Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr Biol 2000, 10:719-722
36. Brandt D, Gimona M, Hillmann M, Haller H, Mischak H: Protein kinase C induces actin reorganization via a Src- and Rho-dependent pathway. J Biol Chem 2002, 277:20903-20910
37. Kontaridis MI, Eminaga S, Fornaro M, Zito CI, Sordella R, Settleman J, Bennett AM: SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol Cell Biol 2004, 24:5340-5352
38. Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H: A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J Hepatol 2000, 32:762-770
39. Murata T, Arii S, Mori A, Imamura M: Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. J Surg Res 2003, 114:64-71
40. Machide M, Hashigasako A, Matsumoto K, Nakamura T: Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase. J Biol Chem 2006, 281:8765-8772
41. Chao W, Liu H, Olson MS: Effect of orthovanadate on tyrosine phosphorylation of P120 GTPase-activating protein in rat liver macrophages (Kupffer cells). Biochem Biophys Res Commun 1993, 191:55-60
42. Moyer KE, Saba AA, Hauck RM, Ehrlich HP: Systemic vanadate ingestion modulates rat tendon repair. Exp Mol Pathol 2003, 75:80-88
43. Ehrlich HP, Keefer KA, Myers RL, Passaniti A: Vanadate and the absence of myofibroblasts in wound contraction. Arch Surg 1999, 134:494-501
44. Iredale JP: Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007, 117:539-548
45. French RJ, Jones PJ: Role of vanadium in nutrition: metabolism, essentiality and dietary considerations. Life Sci 1993, 52:339-346
46. Wenzel UO, Fouqueray B, Biswas P, Grandaliano G, Choudhury GG, Abboud HE: Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy. J Clin Invest 1995, 95:1244-1252
47. Heffetz D, Bushkin I, Dror R, Zick Y: The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 1990, 265:2896-2902
48. Jaeschke H: Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol 2006, 290:G1083-G1088